PTO- 1581 |
Approved for use through 03/31/2024. OMB 0651-0054 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Input Field |
Entered |
SERIAL NUMBER | 88130645 |
---|---|
LAW OFFICE ASSIGNED | LAW OFFICE 105 |
MARK SECTION | |
MARK | TIVDAK (see, http://uspto.report/TM/88130645/mark.png) |
STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
LITERAL ELEMENT | TIVDAK |
OWNER SECTION (current) | |
NAME | SEAGEN INC. |
MAILING ADDRESS | 21823 30TH DRIVE S.E. |
CITY | BOTHELL |
STATE | Washington |
ZIP/POSTAL CODE | 98021 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
OWNER SECTION (proposed) | |
NAME | SEAGEN INC. |
MAILING ADDRESS | 21823 30TH DRIVE S.E. |
CITY | BOTHELL |
STATE | Washington |
ZIP/POSTAL CODE | 98021 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
XXXX | |
CORRESPONDENCE INFORMATION (current) | |
NAME | Harold Milstein |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | svtmdocketing@sheppardmullin.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | NOT PROVIDED |
CORRESPONDENCE INFORMATION (proposed) | |
NAME | Harold Milstein |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | svtmdocketing@sheppardmullin.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | NOT PROVIDED |
DOCKET/REFERENCE NUMBER | 65MK-289600 |
GOODS AND/OR SERVICES SECTION | |
INTERNATIONAL CLASS | 005 |
CURRENT IDENTIFICATION | Pharmaceutical preparations for use in humans, namely, chemotherapeutics and biopharmaceuticals for the treatment of diseases and conditions; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology, ophthalmology, gastroenterological disorders, and tissue and organ transplantology |
GOODS OR SERVICES | KEEP ALL LISTED |
INTERNATIONAL CLASS | 042 |
CURRENT IDENTIFICATION | Biotechnology research, namely, research and development of pharmaceutical preparations for use in humans; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of cancer, autoimmune diseases, inflammatory disorders, gastroenterological disorders and for use in dermatology, oncology, hematology, ophthalmology, and tissue and organ transplantation |
GOODS OR SERVICES | KEEP ALL LISTED |
EXTENSION SECTION | |
EXTENSION NUMBER | 3 |
ONGOING EFFORT | product or service research or development |
ALLOWANCE MAIL DATE | 10/29/2019 |
STATEMENT OF USE | NO |
PAYMENT SECTION | |
NUMBER OF CLASSES | 2 |
SUBTOTAL AMOUNT [EXTENSION FEE] | 250 |
TOTAL AMOUNT | 250 |
SIGNATURE SECTION | |
SIGNATURE | /ChelseaaBush/ |
SIGNATORY'S NAME | Chelseaa Bush |
SIGNATORY'S POSITION | Attorney of Record, California bar member |
DATE SIGNED | 04/15/2021 |
SIGNATORY'S PHONE NUMBER | 16508152600 |
SIGNATURE METHOD | Sent to third party for signature |
FILING INFORMATION | |
SUBMIT DATE | Thu Apr 15 17:16:00 ET 2021 |
TEAS STAMP | USPTO/ESU-XX.XXX.XXX.XX-2 0210415171600741169-88130 645-7705588aba3e79a4fc6d3 fd2ac141fe582f5980fea0a4d 793bc50788f95ea39d85-DA-1 5583084-20210415170229475 010 |
PTO- 1581 |
Approved for use through 03/31/2024. OMB 0651-0054 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |